Cargando…
Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases
Cardiometabolic diseases, including cardiovascular disease, obesity, and diabetes, are the leading cause of mortality and morbidity worldwide. Cardiometabolic diseases are associated with many overlapping metabolic syndromes such as hypertension, hyperlipidemia, insulin resistance, and central adipo...
Autores principales: | Hernandez, Rebecca, Zhou, Changcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692734/ https://www.ncbi.nlm.nih.gov/pubmed/34957242 http://dx.doi.org/10.3389/fcvm.2021.752337 |
Ejemplares similares
-
Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease
por: Lin, Jianguo, et al.
Publicado: (2022) -
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice
por: Lu, Weiwei, et al.
Publicado: (2021) -
Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
por: Arivazhagan, Lakshmi, et al.
Publicado: (2022) -
Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease
por: Oishi, Yumiko, et al.
Publicado: (2018) -
Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity
por: Oishi, Yumiko, et al.
Publicado: (2020)